Advertisement

A Scoping Review of Dementia Symptom Management in Persons with Dementia Living in Home-Based Settings

  • Catherine E. SchneiderEmail author
  • Alycia A. Bristol
  • Abraham Brody
Nursing (R D’Aoust, Section Editor)
  • 17 Downloads
Part of the following topical collections:
  1. Topical Collection on Nursing

Abstract

Background

A large proportion of our older adults live with Alzheimer’s disease and related dementias, and the number of those diagnosed in the future is expected to increase dramatically as the population ages. Persons with dementia bring unique healthcare challenges due to the manifestation of behavioral and psychological symptoms associated with the disease. The lack of geriatric clinicians as well as a properly trained non-geriatric specialist workforce capable of addressing the symptoms persons with dementia exacerbates the challenge of providing effective care. Pharmacological interventions are contraindicated for treatment of most behavioral psychological symptoms of dementia (BPSD). The Centers for Medicare and Medicaid Services now requires that nonpharmacological interventions be used as a first-line treatment. It has not been determined what nonpharmacological intervention for BPSD are most effective and what the infrastructure would entail for such interventions for PWD living at home.

Purpose of Review

The purpose of this study is to examine the literature focusing on interventions aimed towards managing persons’ symptoms of dementia living in home-based settings. A scoping review examining the literature published on this topic over the last 3 years was conducted.

Recent Findings

One thousand twenty-four articles were found, of which nine met inclusion criteria. Five articles used occupation-based therapy, two used exercise therapy, and one article was found utilizing aromatherapy and music therapy.

Summary

The majority of articles used occupation-based therapy as their intervention for BPSD. Overall, research showed nonpharmacological interventions can be effective in helping mange BPSD in persons living in home-based settings, although maintenance effects of interventions should be further explored in future research as well as how to ensure these interventions are more widely utilized by caregivers in this setting.

Keywords

Dementia Nonpharmacological Symptom management Intervention Home-based care 

Notes

Acknowledgement

We want to acknowledge Ann Yoo a nursing student from New York University who helped with formatting and data extraction on this article as a research assistant.

Funding Information

This article was partially supported through funding from NIH grants R01AG056610 and R61AG06190

Compliance with Ethical Standards

Conflict of Interest

Catherine E. Schneider, Alycia A. Bristol, and Ab Brody each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29(1-2):125–32.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Langa KM, Larson EB, Crimmins EM, Faul JD, Levine DA, Kabeto MU, et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med. 2017;177(1):51–8.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology. 2013;80(19):1778–83.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Pérez AR, González SG. The importance of behavioural and pyschological symptoms in Alzheimer’s disease. Neurologia (English Edition), 2018;33(6):378–384.CrossRefGoogle Scholar
  5. 5.
    Cerejeira J, Lagarto L, Mukaetova-Ladinska E. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Armstrong NM, Gitlin LN, Parisi JM, Roth DL, Gross AL. Association of physical functioning of persons with dementia with caregiver burden and depression in dementia caregivers: an integrative data analysis. Aging Ment Health. 2019;23(5):587–594.CrossRefGoogle Scholar
  7. 7.
    Arthur PB, Gitlin LN, Kairalla JA, Mann WC. Relationship between the number of behavioral symptoms in dementia and caregiver distress: what is the tipping point? Int Psychogeriatr. 2018;30(8):1099–107.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Amo-Korankye S, Gul S, Ninan S, Patel-Palfreman M. Alzheimer’s dementia, posterior cortical atrophy variant with BPSD. Progr Neurol Psychiatry. 2019;23(1):19–22.CrossRefGoogle Scholar
  9. 9.
    Matsuoka T, Manabe T, Akatsu H, Hashizume Y, Yamamoto S, Ogawa N et al. Factors influencing hospital admission among patients with autopsy-confirmed dementia. Psychogeriatrics. 2019;19(3):255–263.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Szalontay A, Burtea V, Ifteni P. Predictors of institutionalization in dementia. Rev Cercetare Interventie Soc. 2015;49:249.Google Scholar
  11. 11.
    Toot S, Swinson T, Devine M, Challis D, Orrell M. Causes of nursing home placement for older people with dementia: a systematic review and meta-analysis. Int Psychogeriatr. 2017;29(2):195–208.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Jutkowitz E, Kane RL, Gaugler JE, MacLehose RF, Dowd B, Kuntz KM. Societal and family lifetime cost of dementia: implications for policy. J Am Geriatr Soc. 2017;65(10):2169–75.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Schaller S, Mauskopf J, Kriza C, Wahlster P, Kolominsky-Rabas PL. The main cost drivers in dementia: a systematic review. Int J Geriatr Psychiatry. 2015;30(2):111–29.  https://doi.org/10.1002/gps.4198.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Song J-A, Oh Y. The association between the burden on formal caregivers and behavioral and psychological symptoms of dementia (BPSD) in Korean elderly in nursing homes. Arch Psychiatr Nurs. 2015;29(5):346–54.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Passalacqua SA, Harwood J. VIPS communication skills training for paraprofessional dementia caregivers: an intervention to increase person-centered dementia care. Clin Gerontol. 2012;35(5):425–45.CrossRefGoogle Scholar
  16. 16.
    Buckley JS, Salpeter SR. A risk-benefit assessment of dementia medications: systematic review of the evidence. Drugs Aging. 2015;32(6):453–67.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Schwertner E, Secnik J, Garcia-Ptacek S, Johansson B, Nagga K, Eriksdotter M, et al. Antipsychotic treatment associated with increased mortality risk in patients with dementia. A registry-based observational cohort study. J Am Med Dir Assoc. 2019;20(3):323–9 e2.  https://doi.org/10.1016/j.jamda.2018.12.019.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294(15):1934–43.  https://doi.org/10.1001/jama.294.15.1934.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry. 2015;72(5):438–45.  https://doi.org/10.1001/jamapsychiatry.2014.3018.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. Bmj. 2015;350:h369.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Porsteinsson AP, Drye LT, Pollock BG, Devanand D, Frangakis C, Ismail Z, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. Jama. 2014;311(7):682–91.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Marcum ZA, Perera S, Thorpe JM, Switzer GE, Castle NG, Strotmeyer ES, et al. Antidepressant use and recurrent falls in community-dwelling older adults: findings from the Health ABC Study. Ann Pharmacother. 2016;50(7):525–33.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Dyer SM, Harrison SL, Laver K, Whitehead C, Crotty M. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr. 2018;30(3):295–309.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    National Institute for Health adn Clinical Excellence/Social Care Institute for Excellene. Dementia: supporting people with dementia nard their carers in health and social care. NICE Clinical Guidance 42. London: National Institute for Health and Clinical Excellence; 2007.Google Scholar
  25. 25.
    Oliveira AMD, Radanovic M, Mello PCHD, Buchain PC, Vizzotto ADB, Celestino DL, et al. Nonpharmacological interventions to reduce behavioral and psychological symptoms of dementia: a systematic review. Biomed Res Int. 2015.Google Scholar
  26. 26.
    Testad I, Corbett A, Aarsland D, Lexow KO, Fossey J, Woods B, et al. The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review. Int Psychogeriatr. 2014;26(7):1083–98.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Lepore M, Ferrell A, Wiener JM. Living arrangements of people with alzheimer’s disease and related dementias: implications for services and supports. Washington, DC: Office of the Assistant Secretary for Planning and Evaluation Disability, Aging, and Long-Term Care Policy. 2017.Google Scholar
  28. 28.
    Brien SE, Lorenzetti DL, Lewis S, Kennedy J, Ghali WA. Overview of a formal scoping review on health system report cards. Implement Sci. 2010;5(1):2.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Barton C, Miller B, Yaffe K. Improved evaluation and management of cognitive impairment: results of a comprehensive intervention in long-term care. J Am Med Dir Assoc. 2006;7(2):84–9.  https://doi.org/10.1016/j.jamda.2005.06.008.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Sackett DL, Rosenberg WM, Gray JM, Haynes RB, Richardson WS. Evidence based medicine. BMJ. 1996;313(7050):170.PubMedCentralCrossRefGoogle Scholar
  31. 31.
    • de Oliveira AM, Radanovic M, Homem de Mello PC, Buchain PC, Dias Vizzotto A, Harder J, et al. An intervention to reduce neuropsychiatric symptoms and caregiver burden in dementia: P reliminary results from a randomized trial of the tailored activity program–outpatient version. Int J Geriatr Psychiatry. 2017; This article is “of importance” because it was one of the articles we found in the scoping review of literature that showed positive results from their interveniton using occupaiton therapy at reducing neuropsychiatric symptoms of dementia. It was a rigorous study with high (Level I) levels of evidence through an RCT and the study was conducted within the past 2 years (2017). Google Scholar
  32. 32.
    •• Gitlin LN, Arthur P, Piersol C, Hessels V, Wu SS, Dai Y, et al. Targeting behavioral symptoms and functional decline in dementia: a randomized clinical trial. J Am Geriatr Soc. 2018;66(2):339–45 This article is “of outstanding importance” as it was published last year in 2018. They used occupational therapy as an intervention, which showed not only reductions in number of behavioral symptoms of dementia patients, but also reductions in the severity of the behavioral symptoms. These results were found while conducting rigorous research by conduting an RCT, indicating the highest level of evidence. PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Ikemata S, Momose Y. Effects of a progressive muscle relaxation intervention on dementia symptoms, activities of daily living, and immune function in group home residents with dementia in Japan. Jpn J Nurs Sci. 2017;14(2):135–45.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Liang A, Piroth I, Robinson H, MacDonald B, Fisher M, Nater UM, et al. A pilot randomized trial of a companion robot for people with dementia living in the community. J Am Med Dir Assoc. 2017;18(10):871–8.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Raglio A, Fonte C, Reani P, Varalta V, Bellandi D, Smania N. Active music therapy for persons with dementia and their family caregivers. Int J Geriatr Psychiatry. 2016;31(9):1085–7.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Kaymaz TT, Ozdemir L. Effects of aromatherapy on agitation and related caregiver burden in patients with moderate to severe dementia: a pilot study. Geriatr Nurs. 2016;20:1e7.Google Scholar
  37. 37.
    Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(5 Suppl 6):10S–6S.CrossRefGoogle Scholar
  38. 38.
    Lamb SE, Sheehan B, Atherton N, Nichols V, Collins H, Mistry D, et al. Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial. bmj. 2018;361:k1675.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Pimouguet C, Le Goff M, Wittwer J, Dartigues J-F, Helmer C. Benefits of occupational therapy in dementia patients: findings from a real-world observational study. J Alzheimers Dis. 2017;56(2):509–17.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Straubmeier M, Behrndt E-M, Seidl H, Özbe D, Luttenberger K, Graessel E. Non-pharmacological treatment in people with cognitive impairment: results from the randomized controlled german day care study. Dtsch Arztebl Int. 2017;114(48):815–21.PubMedPubMedCentralGoogle Scholar
  41. 41.
    • Kaymaz TT, Ozdemir L. Effects of aromatherapy on agitation and related caregiver burden in patients with moderate to severe dementia: A pilot study. Geriatr Nurs. 2017;38(3):231–7 This study is “of importance” because it was conducted with the highest level of evidence (level 1) and showed reductions in MPI scores in the intervention group using aromatherapy. Even though this study is a pilot RCT, it is crucial as it informs future research on what to potentially focus on while developing interventions to improve dementia symptom mangement for patients in the future. CrossRefGoogle Scholar
  42. 42.
    Laver K, Cumming R, Dyer S, Agar M, Anstey KJ, Beattie E, et al. Evidence-based occupational therapy for people with dementia and their families: what clinical practice guidelines tell us and implications for practice. Aust Occup Ther J. 2017;64(1):3–10.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Nissen RM, Hersch G, Tietze M, Chang P-FJ. Persons with dementia and their caregivers’ perceptions about occupational therapy and telehealth: a qualitative descriptive study. Home Healthc Now. 2018;36(6):369–78.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Fung JKK, Tsang HW, Chung RC. A systematic review of the use of aromatherapy in treatment of behavioral problems in dementia. Geriatr Gerontol Int. 2012;12(3):372–82.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Anderson AR, Deng J, Anthony RS, Atalla SA, Monroe TB. Using complementary and alternative medicine to treat pain and agitation in dementia: a review of randomized controlled trials from long-term care with potential use in critical care. Crit Care Nurs Clin. 2017;29(4):519–37.CrossRefGoogle Scholar
  46. 46.
    Lerner BS, Kalish V, Ledford CJ. Exploring residents’ skills in diagnosing dementia: the unexpected dissonance between ability and confidence. Fam Med. 2017;49(6):460–3.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012;25(3):367–82.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord. 2009;23(4):306–14.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Aminzadeh F, Molnar FJ, Dalziel WB, Ayotte D. A review of barriers and enablers to diagnosis and management of persons with dementia in primary care. Can Geriatr J. 2012;15(3):85–94.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Braekhus A, Laake K, Engedal K. The Mini-Mental State Examination: identifying the most efficient variables for detecting cognitive impairment in the elderly. J Am Geriatr Soc. 1992;40(11):1139–45.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;1.Google Scholar
  53. 53.
    Chiu MJ, Chen TF, Yip PK, Hua MS, Tang LY. Behavioral and psychologic symptoms in different types of dementia. J Formos Med Assoc. 2006;105(7):556–62.  https://doi.org/10.1016/S0929-6646(09)60150-9.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Logsdon RG, Teri L, Weiner MF, Gibbons LE, Raskind M, Peskind E, et al. Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. J Am Geriatr Soc. 1999;47(11):1354–8.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Catherine E. Schneider
    • 1
    Email author
  • Alycia A. Bristol
    • 1
  • Abraham Brody
    • 1
  1. 1.Hartford Institute for Geriatric NursingRory Meyers College of NursingNew YorkUSA

Personalised recommendations